Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 5.10
-0.07 (-1.35%)
Jun 12, 2026, 5:05 PM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 312.88 million as of June 12, 2026. Its market cap has increased by 22.34% in one year.
Market Cap
312.88M
Enterprise Value
257.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.10
Market Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 312.88M, an increase of 167.22%. That is a compound annual growth rate of 7.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 312.88M | -8.76% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cantargia AB | 537.00M |
| AlzeCure Pharma AB | 491.83M |
| Corline Biomedical AB | 462.56M |
| Intervacc AB | 460.10M |
| Sprint Bioscience AB | 388.30M |
| Ascelia Pharma AB | 375.23M |
| Isofol Medical AB | 221.46M |
| Xbrane Biopharma AB | 220.48M |